Correlation between COX-2 and VEGF-C expressions and lymphatic metastasis in esophageal squamous carcinoma
Pang Xiao
Abstract
Pang Xiao
Abstract
AIM: To investigate the correlation of the expressions of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor-C (VEGF-C) in esophageal squamous carcinoma and their implication in tumor lymphatic metastasis. METHODS: The expressions of COX-2 and VEGF-C were examined by immunohistochemical method in 72 cases of esophageal squamous carcinoma and 24 cases of normal esophageal mucosa. RESULTS: The positive rates of COX-2 and VEGF-C in esophageal squamous carcinoma were 48.6% and 38.9% respectively, and no expressions of COX-2 or VEGF-C were detected in normal esophageal mucosa. The expressions of COX-2 and VEGF-C were signifi- cantly associated with the depth of tumor invasion and lymph node metastasis (P0.01), but not with the patient age, tumor size or differentiation. The expression of COX-2 was closely correlated with that of VEGF-C (contingency coefficient=0.342,P= 0.002). CONCLUSION: COX-2 may participate in VEGF-C lymphangiogenic pathway and play an important role in the lymphatic metastasis of esophageal squamous carcinoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To investigate the correlation of the expressions of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor-C (VEGF-C) in esophageal squamous carcinoma and their implication in tumor lymphatic metastasis. METHODS: The expressions of COX-2 and VEGF-C were examined by immunohistochemical method in 72 cases of esophageal squamous carcinoma and 24 cases of normal esophageal mucosa. RESULTS: The positive rates of COX-2 and VEGF-C in esophageal squamous carcinoma were 48.6% and 38.9% respectively, and no expressions of COX-2 or VEGF-C were detected in normal esophageal mucosa. The expressions of COX-2 and VEGF-C were signifi- cantly associated with the depth of tumor invasion and lymph node metastasis (P0.01), but not with the patient age, tumor size or differentiation. The expression of COX-2 was closely correlated with that of VEGF-C (contingency coefficient=0.342,P= 0.002). CONCLUSION: COX-2 may participate in VEGF-C lymphangiogenic pathway and play an important role in the lymphatic metastasis of esophageal squamous carcinoma.
Key concepts: Medicine, Lymphangiogenesis, Lymphatic system, Immunohistochemistry, Pathology, Carcinoma, Metastasis, Squamous carcinoma